Strategy, advocacy and partnering for the orphan drug industry
World Orphan Drug Congress 2020
Panel: Optimising clinical development strategies for gene therapy.
Full panel to be confirmed.
Samantha Parker, Senior Vice President & Chief Patient Access Officer, Lysogene
Mathew Pletcher, Head of Rare Diseases, Roche
Christeen Moburg, Senior Director, Patient Advocacy, Sangamo Therapeutics